Because of the immunogenicity of the Fc-OPG fusion protein, a fully human monoclonal anti-RANKL antibody, AMG162, has been developed, which showed a rapid decrease in bone turnover of greater than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback